Clinical Trial Update: Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating irofulven in combination with oxaliplatin in advanced solid tumors has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Irofulven (irofulven)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Eisai Inc. | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED